Intellia Therapeutics Inc (NTLA)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
NTLA Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
NTLA Quarterly Deferred Revenue ($0.00 → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
NTLA deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 630,000 | |
| 7,290,000 | |
| 12,247,000 | |
| 17,154,000 | |
| 20,661,000 | |
| 20,661,000 | |
| 22,155,000 | |
| 22,184,000 | |
| 22,184,000 | |
| 22,140,000 | |
| 13,347,000 | |
| 21,933,000 | |
| 35,343,000 | |
| 43,839,000 | |
| 54,818,000 | |
| 61,806,000 | |
| 63,759,000 | |
| 63,759,000 | |
| 56,759,000 | |
| 22,544,000 | |
| 22,544,000 | |
| 22,544,000 | |
| 22,544,000 | |
| 37,927,000 | |
| 12,639,000 | |
| 12,674,000 | |
| 15,822,000 | |
| 19,652,000 | |
| 23,431,000 | |
| 27,122,000 | |
| 14,268,000 | |
| 15,678,000 | |
| 17,062,000 | |
| 21,188,000 | |
| 17,653,000 | |
| 18,792,000 | |
| 19,917,000 | |
| 20,178,000 | |
| 17,166,000 | |
| 16,287,000 | |
| 6,781,000 | |
| 6,547,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |